Endothelin-1

Endothelin-1

Target · Vasoactive peptide

Endothelin-1 Endothelin-1 · ET1

Endothelin-1 (EDN1, ET1) is a secreted, endothelium-derived peptide of the endothelin/sarafotoxin family and a potent vasoconstrictor. It acts as a probable ligand for the G protein-coupled receptors EDNRA and EDNRB. Browse Assay Genie's current range of Endothelin-1 research reagents below, or read on for the biology behind the target.

Secreted peptidePotent vasoconstrictorEndothelin/sarafotoxin family
212 aa
Protein length
~24 kDa
Molecular weight
6p24.1
Gene locus
Endothelin
Protein family
Target information

What is Endothelin-1 (endothelin 1)?

Endothelin-1 is an endothelium-derived vasoconstrictor peptide. It is a probable ligand for the G protein-coupled receptors EDNRA and EDNRB, and in glomerular mesangial cells this signalling activates PTK2B, BCAR1, BCAR3 and the RAP1 and RHOA GTPase cascades. Endothelin-1 also binds the DEAR/FBXW7-AS1 receptor. In the mesenteric arterial wall it promotes remodelling through ROCK signalling, which drives colocalisation of NFATC3 with F-actin filaments. NFATC3 then translocates to the nucleus and promotes transcription of ACTA2, a marker of smooth muscle hypertrophy and differentiation.

The EDN1 gene encodes a preproprotein that is proteolytically processed to give the secreted Endothelin-1 peptide. The peptide belongs to the endothelin/sarafotoxin family, and EDN1 sits in the HGNC endothelins gene group alongside EDN2 and EDN3. Alternative splicing of the gene produces multiple transcript variants. The mouse and rat orthologues are both named Edn1.

Endothelin-1 is a potent vasoconstrictor, and its cognate receptors are therapeutic targets in the treatment of pulmonary arterial hypertension. Aberrant expression of the gene may promote tumorigenesis. This makes Endothelin-1 a frequent subject in vascular biology, receptor pharmacology and cancer research, where measuring the peptide, its precursor and its receptors helps to define pathway activity.

Vascular biology

Endothelin-1 is an endothelium-derived vasoconstrictor peptide, making it central to studies of vessel tone and arterial wall remodelling.

Pulmonary arterial hypertension

The cognate receptors of Endothelin-1 are therapeutic targets in pulmonary arterial hypertension, so the peptide is studied in disease mechanism and pharmacology.

GPCR signalling research

Endothelin-1 is a probable ligand for EDNRA and EDNRB, activating PTK2B, BCAR1, BCAR3, RAP1 and RHOA cascades in mesangial cells.

Cancer biology

Aberrant EDN1 expression may promote tumorigenesis, prompting investigation of endothelin signalling in tumour development.

Background

Endothelin-1 frequently asked questions

What does Endothelin-1 do?

Endothelin-1 is a secreted, endothelium-derived vasoconstrictor peptide. It is a probable ligand for EDNRA and EDNRB. It also promotes mesenteric arterial wall remodelling through ROCK signalling and NFATC3-driven transcription of the smooth muscle marker ACTA2.

What are the other names for Endothelin-1?

Endothelin-1 is encoded by the EDN1 gene, and ET1 is a commonly used alias. The gene encodes a preproprotein that is proteolytically processed into the secreted peptide. Alternative splicing gives multiple transcript variants. Check the datasheet of any product for its validated reactivity.

Is Endothelin-1 conserved and linked to disease?

Mouse and rat both carry an Edn1 orthologue. In humans, the peptide's receptors are therapeutic targets in pulmonary arterial hypertension, and aberrant EDN1 expression may promote tumorigenesis. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other endothelin family members and the endothelin receptors that mediate Endothelin-1 signalling.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P05305; product specifications from Assay Genie datasheets.

Endothelin-1 Product listing